Search the Newsreel

First-half 2026 results

Clariane Half-Year Results: strong improvement in operating performance Successful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood at €2,699m, up +4.6% on an organic basis supported by volume growth of +1.6% and price gain of +3.0% …

RiskMark wins Best AI Tool For Lawyers at the 2026 CODiE awards

RiskMark, an AI-powered trademark risk assessment solution by Clarivate, has won the Best AI Tool for Lawyers at the 2026 CODiE Awards, following its 2025 LegalTech Breakthrough Award. The platform helps legal professionals assess the likelihood of confusion, identify potential trademark conflicts, and develop …

Earnings call transcript: Clarivate posts mixed Q2 2026 results as shares fall

Clarivate Plc Q2 2026 Earnings Call Summary - Moby Strategic Execution and Portfolio Optimization Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Clarivate PLC (CLVT) reported $587.3 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 5.5%. EPS of $0.19 for the same period compares to $0.18 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $587.06 …

Clarivate Releases Q2 2026 Financial Results

Clarivate Plc (CLVT) announced its Q2 2026 financial results, reporting an adjusted diluted EPS of $0.19, surpassing analyst estimates. The company generated $587.3M in revenue, a 5.5% year-over-year decrease, with organic ACV growth of 1.5%. Clarivate provided FY 2026 guidance, projecting adjusted EPS between …

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Clarivate PLC (CLVT) reported strong Q2 results, with earnings of $0.19 per share surpassing the Zacks Consensus Estimate of $0.17 and revenues of $587.3 million beating expectations by 0.04%. Despite these beats and positive past performance in exceeding EPS estimates, Clarivate's stock has declined …

Clarivate appoints Michael Easton as chief financial officer

Clarivate Plc has appointed Michael Easton as its new Executive Vice President and Chief Financial Officer, effective August 8, 2026. Easton, who currently serves as Clarivate's Senior Vice President and Chief Accounting Officer, brings over 25 years of experience in finance. He will replace …

Clarivate PLC 2026: Revenue $587.3M, EPS ($0.42) — 10-Q Summary

Clarivate PLC reported its Q2 2026 results, showing a decline in revenue to $587.3M from $621.4M in the prior year, and an increased net loss resulting in an EPS of ($0.42) compared to ($0.11) previously. Key factors included product wind-downs, lower transactional activity, and …

Clarivate Plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:CLVT) 2026-07-29

Clarivate Plc (NYSE:CLVT) published its Q2 2026 earnings call presentation on July 29, 2026. The company reported an EPS of $0.19, beating estimates by $0.01, and revenue of $587.30M, which missed estimates by $2.46M and represented a 5.49% year-over-year decrease. The presentation was released …

Clarivate Analytics Non-GAAP EPS of $0.19 beats by $0.01, revenue of $587.3M misses by $2.46M

* Clarivate Analytics press release [https://seekingalpha.com/pr/20598844-clarivate-reports-second-quarter-2026-results] (CLVT [https://seekingalpha.com/symbol/CLVT]): Q2 Non-GAAP EPS of $0.19 beats by $0.01. * Revenue of $587.3M (-5.5% Y/Y) misses by $2.46M. * 2026 outlook (reaffirmed): * Adjusted diluted EPS: $0.70–$0.80 (vs. consensus of $0.73) * Revenue (including discontinued operations): $2.30B–$2.42B …

CLARIVATE earnings beat by $0.01, revenue fell short of estimates

CLVT|Clarivate PLC|Price:1.820|Chg%:-0.040

Clarivate Q2 Earnings Call Highlights

Clarivate Shares Slip After Mixed Second-Quarter Results Despite Earnings Beat

Clarivate Reports Second Quarter 2026 Results

Clarivate Plc reported its second quarter 2026 results, showing continued progress on its strategic and financial priorities through its Value Creation Plan. The company reaffirmed its full-year 2026 financial outlook, anticipating ACV Organic Growth between 2.0% and 3.0% and Adjusted EBITDA of $980M to …

Clarivate Number of Employees 2026 | Employee Count & Headcount Data

Clarivate Plc (CLVT) had approximately 12,120 employees worldwide as of March 2026, marking a 3.5% growth from 2023 but a 0.8% decline year over year. The company's workforce is primarily concentrated in India, the United States, and Serbia, with an average salary of $54,277 …

Aclaris Therapeutics Market Sentiment

This article provides an overview of market sentiment for Aclaris Therapeutics (ACRS), highlighting key signals such as analyst consensus, short interest, options flow, and insider activity. Analysts show an "Outperform" consensus with an average price target significantly above the current price, while short interest …

Aclaris Therapeutics Inc (ACRS) Financial Health: Profitability & Balance Sheet Analysis

Aclaris Therapeutics Inc (ACRS) has a weak financial status and low operating efficiency, ranking 281 out of 385 in the Biotechnology & Medical Research industry with a current financial score of 6.19. Despite this, its latest quarterly revenue increased by 37.18% year-over-year to $2.00M, …

Clarivate (NYSE:CLVT) Trading Up 7.3% - Here's What Happened

Clarivate (NYSE:CLVT) shares rose 7.3% in midday trading on Tuesday but traded on significantly reduced volume. Despite beating earnings expectations and some analyst price target increases, the stock maintains a consensus "Reduce" rating from analysts. The company reported a revenue decline year-over-year and remains …

Claritev Corporation Revenue Breakdown – NYSE:CTEV

Clarivate earnings up next: Value plan faces quarterly test By Investing.com

Clarivate (CLVT) is set to report second-quarter earnings, with investors focused on whether its "Value Creation Plan" is improving efficiency despite stagnant revenue. Analysts anticipate earnings of 18 cents per share on $589.7 million in revenue, a 5.1% year-over-year decline. The company's recent sale …

Aclaris Therapeutics Inc (ACRS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Aclaris Therapeutics Inc (ACRS). It notes that Aclaris Therapeutics has not distributed any dividends over the past five years and contains no data regarding past dividend payments or stock splits.

Aclaris Therapeutics Inc (ACRS) Cash Flow

This article provides a detailed cash flow statement for Aclaris Therapeutics Inc (ACRS), including operating, investing, and financing cash flows, presented both quarterly and annually. It also defines these cash flow components and highlights Aclaris Therapeutics Inc's performance in each area, such as its …

CLVT|Clarivate PLC|Price:2.146|Chg%:+0.106

Clarivate PLC is a global provider of transformative intelligence in Academia & Government, Intellectual Property, and Life Sciences & Healthcare sectors. The article details its business scope, financial data, and market performance, including its stock symbol (CLVT), current stock price, market capitalization, and key …

Clarivate PLC (CLVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Clarivate PLC (CLVT) revenue breakdown reveals that subscription revenues constitute the largest portion at 65.39% ($1.61B), followed by re-occurring revenues at 17.68% ($434.20M). Geographically, the Americas account for over half of the revenue at 53.07% ($1.30B), while Europe/Middle East/Africa and Asia Pacific contribute 26.67% …

Clarivate (CLVT) Wins AI Contracts, Is The Stock Still Undervalued?

Clarivate (CLVT) has secured significant AI contracts with the U.S. Patent and Trademark Office and France's national academic library system, highlighting its AI capabilities. Despite these wins, the stock has experienced significant price declines, suggesting weakening investor sentiment. Analysts and intrinsic value estimates indicate …

Kalehua Capital Management LLC Makes New $6.87 Million Investment in Aclaris Therapeutics, Inc. $ACRS

Aclaris Therapeutics Inc (ACRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Aclaris Therapeutics Inc (ACRS), detailing its business segments. As of the latest disclosed information, the company generated $5.95 million (76.08%) from Licensing and $1.87 million (23.92%) from Laboratory Research Revenue. Regional revenue data has not yet been …

Clarivate PLC (CLVT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Clarivate PLC's (CLVT) dividend history and stock splits. It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent dividend payouts. The article presents a table for dividend dates (Dividend, Record …

Bollard Group LLC Reduces Position in Aclaris Therapeutics, Inc. $ACRS

Aclaris Therapeutics Inc (ACRS) Institutional Confidence

This article analyzes the institutional confidence in Aclaris Therapeutics Inc (ACRS), noting its score of 7.00, which ranks 80th in its industry. Institutional shareholding decreased by 32.53% quarter-over-quarter, with James Simons being the largest institutional shareholder. The article lists key institutional shareholders and their …

Clarivate PLC (CLVT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Clarivate PLC's (CLVT) shareholder structure, listing major shareholders, their proportionate holdings, and the types of shareholder entities. It also includes institutional shareholding data over several quarters and details on shareholder activity with changes in holdings for top …

Clarivate PLC Revenue Breakdown – HAN:16A

Clarivate PLC (HAN:16A) generated a total revenue of ‪2.09 billion EUR last year. Its top-performing segment, Academia & Government, contributed ‪1.08 billion EUR. The United States was the largest regional contributor, accounting for ‪1.02 billion EUR of the company's revenue.

Price to earnings forward of Clarivate PLC – SWB:16A

This article provides financial information for Clarivate PLC (SWB:16A) on TradingView, specifically focusing on its forward price-to-earnings ratio. It mentions that market data is provided by ICE Data Services and FactSet, and SEC filings by Quartr. The content mainly consists of navigation and boilerplate …

KBC Group NV Makes New Investment in Clarivate PLC $CLVT

KBC Group NV has made a significant new investment in Clarivate PLC (NYSE:CLVT), acquiring over 1.6 million shares valued at $4.1 million in the first quarter of 2026. This move increases institutional ownership in Clarivate, which currently stands at 85.72%. Despite new interest from …

Clarivate PLC $CLVT Shares Sold by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC significantly reduced its stake in Clarivate PLC (NYSE:CLVT) by 34.1% during the first quarter, selling over 22 million shares. Despite this, Clarivate remains Clarkston's second-largest holding. Clarivate recently reported better-than-expected quarterly earnings and revenue, though revenue saw a slight year-over-year …